研究文章
差距在初级保健能力在资源匮乏的地区实施必要的非传染性疾病的干预措施
表3
可用性百分比定义的选择在初级保健机构基本药物在8个国家地区,2009/2011。
|
| 选择基本药物 |
贝宁
() |
厄立特里亚
() |
苏丹
() |
叙利亚
() |
不丹
() |
斯里兰卡
() |
越南
() |
苏里南
() |
|
| 阿替洛尔 |
8.3 |
0.0 |
42.9 |
14.3 |
0.0 |
69.2 |
93.3 |
100.0 |
| 卡托普利 |
33.3 |
0.0 |
28.6 |
14.3 |
0.0 |
69.2 |
60.0 |
30.0 |
| 氨氯地平 |
58.3 |
0.0 |
50.0 |
0.0 |
0.0 |
69.2 |
86.7 |
80.0 |
| 氢氯噻嗪 |
75.0 |
100.0 |
35.7 |
14.3 |
85.7 |
69.2 |
40.0 |
90.0 |
| 硝酸异山梨酯 |
0.0 |
0.0 |
0.0 |
21.4 |
0.0 |
69.2 |
60.0 |
90.0 |
| 速尿灵 |
83.3 |
50.0 |
85.7 |
92.9 |
14.3 |
69.2 |
86.7 |
100.0 |
| 辛伐他汀、洛伐他汀 |
8.3 |
0.0 |
35.7 |
7.1 |
0.0 |
23.1 |
46.7 |
50.0 |
| 胰岛素长期代理 |
0.0 |
0.0 |
21.4 |
21.4 |
0.0 |
30.8 |
0.0 |
80.0 |
| 胰岛素可溶 |
0.0 |
0.0 |
28.6 |
21.4 |
0.0 |
30.8 |
0.0 |
80.0 |
| 二甲双胍 |
25.0 |
0.0 |
42.9 |
14.3 |
0.0 |
69.2 |
53.3 |
100.0 |
| 格列本脲 |
41.7 |
0.0 |
71.4 |
21.4 |
14.3 |
69.2 |
33.3 |
100.0 |
| Beclometasone吸入器 |
33.3 |
16.7 |
21.4 |
28.6 |
0.0 |
15.4 |
6.7 |
80.0 |
| 强的松 |
0.0 |
0.0 |
42.9 |
7.1 |
0.0 |
69.2 |
93.3 |
90.0 |
| 沙丁胺醇吸入器 |
33.3 |
100.0 |
71.4 |
78.6 |
0.0 |
30.8 |
20.0 |
90.0 |
| 舒喘灵片 |
66.7 |
100.0 |
85.7 |
14.3 |
100.0 |
69.2 |
93.3 |
90.0 |
| Ipratropium溴化 |
0.0 |
0.0 |
14.3 |
14.3 |
0.0 |
30.8 |
0.0 |
20.0 |
| 阿斯匹林 |
100.0 |
100.0 |
100.0 |
21.4 |
0.0 |
69.2 |
100.0 |
100.0 |
| 对乙酰氨基酚 |
100.0 |
100.0 |
92.9 |
0.0 |
100.0 |
69.2 |
100.0 |
100.0 |
| 布洛芬 |
83.3 |
100.0 |
100.0 |
0.0 |
100.0 |
69.2 |
73.3 |
80.0 |
| 吗啡(口语) |
0.0 |
0.0 |
14.3 |
0.0 |
0.0 |
15.4 |
0.0 |
20.0 |
| 吗啡注射 |
8.3 |
0.0 |
14.3 |
0.0 |
0.0 |
38.5 |
0.0 |
20.0 |
| 可待因 |
8.3 |
0.0 |
35.7 |
0.0 |
0.0 |
15.4 |
33.3 |
60.0 |
| 注射用葡萄糖溶液 |
91.7 |
0.0 |
0.0 |
0.0 |
57.1 |
53.8 |
66.7 |
80.0 |
| 氯化钠输液 |
91.7 |
100.0 |
92.9 |
35.7 |
0.0 |
53.8 |
100.0 |
60.0 |
| 苄星青霉素 |
50.0 |
100.0 |
92.9 |
57.1 |
30.8 |
0.0 |
60.0 |
100.0 |
|
|
